BioCube completes initial phase development of environmentally safe decontamination system

Spring Creek Capital Corporation (OTCBB: SCRK), a Nevada corporation, announced today that one of its portfolio companies, BioCube, Inc., has completed the initial phase of the development of an environmentally safe decontamination system, utilizing an aerosol-based delivery method of aqueous solution. The key result of this phase is availability of the prototype unit that will undergo significant testing by BioCube and independent laboratories.

BioCube anticipates having several of these prototype units available for tests and demonstrations within the next 45-90 days.

BioCube, Inc. a Nevada corporation, is collaborating with its Russian research partners to complete the development of the system, followed by commercial development and distribution of the system. The decontamination system already has demonstrated effective destruction of microbial and fungal cells, spores, and viruses.

BioCube will focus on the following target markets:

-- Healthcare (hospitals and nursing homes) -- Travel (airplanes, cruise ships, mobile homes) -- Mold remediation -- Schools -- Animal farming -- Agriculture

BioCube believes that its decontamination technology holds significant promise as a long-term solution to a global problem, offering an effective method for rapid, inexpensive and environmentally safe remediation of facilities that may have been contaminated by pathogens.

Source:

Spring Creek Capital Corporation

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.